Sort By:

Human Amyloid Imaging 2012

News Focus: 2012 Human Amyloid Imaging Conference Miami: Amyloid PET in the Clinic: What Are the Issues? Miami: Scan and Tell? Amyloid Imaging Confronts Disclosure Dilemma Miami: Can the Naked Eye Tell When a Scan Is Positive? Miami: When Does Amyloid ...

Human Amyloid Imaging 2013

Solanezumab Selected for Alzheimer’s A4 Prevention Trial HAI—Spotlight on Tau Tracers at Human Amyloid Imaging Meeting HAI—Amyloid Imaging in the Clinic: New Guidelines and Data HAI—Sharper Curves: Revamping a Biomarker Staging Model HAI—Standardizing ...

American Academy of Neurology 2007

Boston: Clinical Trial Results for Dimebon Unveiled Boston: Resting State MRI Shows Loss of Network Connectivity Early in AD American Academy of Neurology: 2007 Annual Meeting ...

Clinical Trials Conference on Alzheimer's Disease 2009

Las Vegas: New Partner, New Game Plan for Lou Ruvo Brain Institute Las Vegas: AD, Risk, ApoE—Tomm40 No Tomfoolery Las Vegas: Prevention Prominent at CTAD Las Vegas: 2020 Vision—AD Prevention in 11 Years? Clinical Trials Conference on Alzheimer’s Disease ...

Clinical Trials Conference on Alzheimer's Disease 2011

Nutrient Formulation Appears to Grease Memory Function Door Slams on RAGE Whence and Where To: History and Future of AD Therapy Trials Clinical Trials: Making “Protocols From Hell” Less Burdensome EEG: Coming in From the Margins of Alzheimer’s Research? ...

Society for Neuroscience Annual Meeting 2013

Researchers Revel in C9ORF72 Advances at RNA Symposium Profilin-1 Links Cytoskeleton and RNA Aggregation in ALS The Four Stages of TDP-43 Proteinopathy Blocking a MicroRNA Slows Motor Neuron Disease in Mice Glial Cells Refine Neural Circuits Innate Immune ...

Clinical Trials Conference on Alzheimer's Disease 2012

CTAD: Turning the Ship Around Toward Early Trials CTAD: New Data on Sola, Bapi, Spark Theragnostics Debate CTAD: Regulatory Science Gains Prominence in AD Research CTAD: Adaptive Antibody Trial to Try Bayesian Statistics CTAD: ApoE Carriers Sought for ...

Patient Engagement in Clinical Trials

A Conference Devoted to Better Engaging Clinical Trial Volunteers Turning to the Internet for Alzheimer’s Trial Volunteers Patient Engagement in Clinical Trials ...

Clinical Trials Conference on Alzheimer’s Disease 2013

Are New Cognitive Tests Ready For Preclinical Trials? Do Tau Tracers Track Cognitive Decline in Disease? Growth Factor Therapy: Safe in Phase 1, Awaiting Efficacy Data Clinical Trials Conference on Alzheimer’s Disease 2013 ...

BACE Proteases in Health and Disease

Cloistered Retreat Takes the Pulse of BACE Research BACE—Substrates, Functions, Developmental Phenotypes Blocking BACE—Do Adult Mouse Phenotypes Predict Side Effects? Meeting Explores Complex Biology of BACE Regulation BACE Proteases in Health and Disease ...

G8 Dementia Summit

European Project Mixes Adaptive Design with Trial-Ready Cohort G8 Vows to Improve Care, Cure Dementia G8 Dementia Summit ...

Keystone Symposium: Alzheimer’s Disease Beyond Aβ

Copper Mountain: Can CREB Save Memory? Copper Mountain: Knight Vision—SIRT1 Aids ADAM10, Slays Aβ Copper Mountain Brief: Rat-a-tat—New Model Comes a Knockin’ Copper Mountain: Death and Trophin Receptors—New Insight, New Drugs? Copper Mountain: Fractious ...

Keystone Symposium: Alzheimer's Disease

Keystone: γ Slowly Relinquishes Its Secrets Keystone: Lipids Grease γ-Secretase Activity Keystone: Loss Versus Gain—Mutations a Drag on γ-Secretase Fiendishly complicated, γ-secretase has proved a formidable foe to the structurally minded scientist. But ...

Current Filters

No filters selected

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From